Uncommon
PrivateLast Round
Series A
Jun 9, 2023
Total Funding Raised
$33.77M
Company Overview
Uncommon is a biotechnology company that developed RNA-based technology for cultivated meat production before pivoting to focus on programmable RNA therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Uncommon Comparables
Compare Uncommon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eleven Therapeutics | 58% | |
| CamGene Therapeutics | 58% | |
| SymphoRNA | 58% |
Uncommon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 9, 2023 | ||||
| Grant | Feb 1, 2021 | ||||
| Seed | Jan 1, 2020 | ||||
| Pre Seed | Nov 1, 2018 |
Uncommon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| East Alpha | Series A |
| Lowercarbon Capital | Series A |
| Balderton Capital | Series A |
| Redalpine | Series A |
Uncommon Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Uncommon's valuation, stock price, and market status.
Is Uncommon a public or private company?
Uncommon is a private company.
What is the current stock price of Uncommon?
Uncommon is a private company with no public stock price. No recent secondary market data is available.
How much is Uncommon worth (valuation)?
Valuation information for Uncommon is not publicly available.
Can I buy Uncommon stock?
Uncommon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Uncommon's last funding round?
Uncommon's most recent funding round was Series A on June 9, 2023.
Who are the main investors in Uncommon?
Key investors in Uncommon include Innovate UK, Lowercarbon Capital, Balderton Capital.
Will Uncommon IPO soon?
No public IPO plans have been announced for Uncommon.
How can I track Uncommon secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Uncommon's secondary market activity and sign up for updates.